Effectiveness Of The Pigeon Pox Vaccine On The Chicken Vaccinated With Avian Influenza Vaccine
Mikhael, C., Fathy, N. (2019). Effectiveness Of The Pigeon Pox Vaccine On The Chicken Vaccinated With Avian Influenza Vaccine. EKB Journal Management System, 4(2), 62-70. doi: 10.21608/javs.2019.62659
Christine A. Mikhael; Nada A. Fathy. "Effectiveness Of The Pigeon Pox Vaccine On The Chicken Vaccinated With Avian Influenza Vaccine". EKB Journal Management System, 4, 2, 2019, 62-70. doi: 10.21608/javs.2019.62659
Mikhael, C., Fathy, N. (2019). 'Effectiveness Of The Pigeon Pox Vaccine On The Chicken Vaccinated With Avian Influenza Vaccine', EKB Journal Management System, 4(2), pp. 62-70. doi: 10.21608/javs.2019.62659
Mikhael, C., Fathy, N. Effectiveness Of The Pigeon Pox Vaccine On The Chicken Vaccinated With Avian Influenza Vaccine. EKB Journal Management System, 2019; 4(2): 62-70. doi: 10.21608/javs.2019.62659

Effectiveness Of The Pigeon Pox Vaccine On The Chicken Vaccinated With Avian Influenza Vaccine

Journal of Applied Veterinary Sciences
Article 9, Volume 4, Issue 2, October 2019, Page 62-70  XML PDF (516.44 K)
Document Type: Original Article
DOI: 10.21608/javs.2019.62659
View on SCiNiTO View on SCiNiTO
Authors
Christine A. Mikhael email 1; Nada A. Fathy2
1Central Laboratory for Evaluation of Veterinary Biologics, Abbasia, Cairo, Egypt
2Veterinary Serum and Vaccine Research Institute, Abbasia, Cairo,
Abstract
Evaluation of the effectiveness of pigeon pox (PP) vaccine in improvement the required immunity to avian influenza (AI) virus vaccine in birds and reducing its shedding after challenge was the object of this study.Specific pathogen free chicks were vaccinated with PP and AI in 10 groups at 5 and/or 8 days of age and/or boosted after 35 days then challenged after 28 days with virulent highly pathogenic AI virus local Egyptian field isolate. The development of immune responses to AI haemagglutinine was recorded and also AI virus shedding after challenge.Vaccinated 10 groups induced protective immune responses; especially in the groups which were boosterly vaccinated with PP vaccine. All birds vaccinated and experimentally challenged 28 days later were protected against virulent AI (H5N1); mild clinical signs of infection developed in few number of vaccinated birds. In contrast, all unvaccinated birds died within 72 hours of challenge. Vaccination of chicks with PP and AI vaccines provided good effectiveness of the PP vaccine on the immune response of vaccinated birds with AI vaccine and showed decreasing in shedding after challenge; especially in the groups which take a booster vaccination of PP and AI vaccine. Although eradication still remain the 1st of choice for controlling the AI in the circumstances of a continuing and wide spread outbreak, but also the availability of new designing future vaccination regime by using avipox virus vaccine should be applied.
Keywords
chickens; pigeon pox vaccines; Avian influenza; shedding; prim-boost
References

ALI A., MARWA SAFWAT, WALID H. KILANY, ABDOU NAGY, AWAD A. SHEHATA, MOHAMED A. ZAIN EL-ABIDEEN,AL. HUSSIEN M. DAHSHAN1 AND ABDEL-SATAR ARAFA A. 2019. Combined H5ND inactivated vaccine protects chickens against challenge by different clades of highly pathogenic avian influenza viruses subtype H5 and virulent Newcastle disease virus. Veterinary World, EISSN: 2231-0916 . Vol 12(1): 97-105.

ALLAN, W.H, J.E. LANCASTER AND TOTH, B.1978. Newcastle disease vaccines their production and use. FAO Animal Production and Health Seriesho. 10 FAO.Rome. Italy.

ANON 1971.  Methods for examining poultry biologics and for identification and quantifying avian pathogens. Newcastle disease, US National Academy of sciences, Wasinghton DC, pp: 66.

BEARD, C. W., SCHNITZLEIN, W. M. AND TRIPATHY, D. N. 1991. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Dis, 35, 356-359.

BOEHRINGER 2017. Prime-Boost Vaccination in Egypt: Field Experiences. Information from the Avian Flu Forum hosted by Boehringer. By ludmila starostina. 5m Publishing, England.

BOSSINGER, T.R.; WINTERFIELD, R. W.; FELDMAN, D.S. AND DHILLON, Α. S. 1982. Psittacine pox virus: virus isolation and identification, transmission and crosschallenge studies in parrots and chickens. Avian Dis, 26: 437 – 444.

BRAMES, H. AND MAYR A. 2006. Safety and Effectiveness of Paramunization in Import Reptiles. Diss. Med. Vet., Munchen. Qmvet.de. researchgate. Net.

BRANDLY, C. A. Y. AND DUNLOP G. L. 1939. Studies on certain filterable viruses. II Immunization against fowl pox with fowl pox and pigeon pox viruses cultivated in vivo and in vitro. J. Amer. Vet. Med. Ass., 95, 430-349.

BUBLOT M., PRITCHARD N., SWAYNE DE., SELLECK P., KARACA K., SURAREZ DL., AUDONNET JC, AND MICKLE TR. 2006. Development and use of fowlpox vectored vaccines for avian influenza. Ann N Y Acad Sci. 1081:193-201.

BYC SUPPORT 2012. 49 Comments/ 243.9K/ Injuries, Diseases, and Cures.

COTTRAL, G.E. 1978. pox viruses. In a journal of standardized methods for veterinary microbiology. Ed. E.g. cottral corner university press (Itha-ca and London) , pp 273-291.

DALLING, T. 1933. Recent progress in the investigation of poultry diseases. Vet. J., 89, 441-449.

 DIENER, K. R., E. L. LOUSBERG, E. L. BEUKEMA, A. YU, P. M. HOWLEY, M. P. BROWN, AND J. D. HAYBALL 2008. Recombinant fowlpox virus elicits transient cytotoxic T-cell responses due to suboptimal innate recognition and recruitment of T-cell help. Vaccine, 26:3566–3573.

EGYPTIAN STANDARD PROTOCOL 2017. Egyptian standards regulation for evaluation of veterinary vaccinations 3rd edition.

ELLIS TM, SIMS LD, WONG HK, WONG CW, DYRTING KC. AND CHOW KW2006. Use of avian influenza vaccination in Hong Kong. DevBiol (Basel). 124:133–43.

GIOTIS E. S. AND 2019 SKINNER M. A. 2019.  Spotlight on avian pathology: Fowlpox virus. Avian pathology 48(2), 87-90.

GOLDHAFT, T.M. 1956. A new method of application of pigeon pox vaccine. J. Amer. Vet. Med, Ass., 128:596-601.

GOTTSTEIN, Ζ.; CIGLAR G. I.; HORVATEK, D.; PRUKNER-RADOVCIC, E.; CAJAVEC, S. AND MAZIJA, H. 2004. Safety and immunogenicity of pigeon pox virus vaccine applied to newly hatched chickens by means of nebulisation, In : Book of Αbstracts XXII World Poultry Congress, Istanbul, Turkey.

GRAHAM, R. AND BRANDLY E.H. 1940.  Immunization against pox in domestic fowl. Illinois Agr Exp. Sta. Bull., 470, 75pp.

HALA, M. E.; MICHAEL, A. I. AND NAMAA, A. M. 2008.  Immunomodulation effect of pigeon pox vaccine in chicken vaccinated with IBDV strains. Proceedings of the Middle East & North Africa (MENA) Region Animal Wealth Research Conference. Future of animal wealth, Cairo International Convention Center, Egypt, ,pp. 140-148.

HY-LINE 2019.  Copyright 2019 Hy-Line International Fowl Pox Prevention Website design and development bySpindustry Digital, Des Moines, Iowa.

JOHNSTON J. B. AND GRANT MCFADDEN 2003. MINIREVIEW: Poxvirus Immunomodulatory Strategies: Current Perspectives. Journal of Virology, p. 6093–6100 Vol. 77, No. 11.

KUMAR M, CHU HJ, RODENBERG J, KRAUSS S. AND WEBSTER RG. 2007. Association of serologic and protective responses of avian influenza vaccines in chickens. Avian Diseases, 51:481–3.

LEE D., YUK S., PARK J., KWON J., ERDENE T., NOH J., YU S.HWANG S., LEE S. AND SONG C. 2013. Innate immune response gene expression profiles in specific pathogen free chickens infected with avian influenza virus subtype H9N2.Springer.BioChip Journal; Vol.7.issue 4, PP 303-398.

MESEKO C. A., SHITTU I. A., AND AKINYEDE O. 2012. Seroprevalence of Fowl Pox Antibody in IndigenousChickens in Jos North and South Council Areas ofPlateau State, Nigeria: Implication for Vector Vaccine 2International Scholarly Research NetworkISRN Veterinary ScienceVolume 2012, Article ID 154971, 4 pages.

MICHAEL A.; NASSAR N.I. AND EL SABBAGH A.1986. Combined vaccination with pigeon and fowl pox vaccines. Second Sci. Con., Fac. Vet.Med., Assiut Univ. AssiutVet.Med. J. Vol. 16, No. 31. P:365-380.

MICHEL B, NIKKI P, DAVID E. S, PAUL S, KEMAL K, DAVID L. S, JEAN-, AND THOMAS R. M .2006. Development and Use of Fowlpox Vectored Vaccines for Avian Influenza. 254, rue Marcel M´erieux, 69007 Lyon, France. Voice: 33-4-7272-5973; fax: 33-4-7272-3316.

NIQUEUX E. ,GUIONIE O., AMELOT M. AND JESTIN V. 2013. Prime-boost vaccination with recombinant H5-fowlpox andNewcastle disease virus vectors affords lasting protection in SPFMuscovy ducks against highly pathogenic H5N1 influenza virus. Vaccine.28;31 (38) :4121-8. doi: 10.1016/j.vaccine.2013.06.074. Copyright © 2013 Elsevier Ltd. All rights reserved.

OIE. 2012.  Sheep pox and goat pox. In: Terrestrial Animal Health Code. World Organization for Animal Health, Paris, France.

OIE.2016. OIE Terrestrial manual, chapter 3.3.4Avian influenza. P:821-843.

OIE. 2019. OIE Terrestrial manual, chapter 3.3.10 Fowlpox. 906-913.

OKWOR, E.C., EZE, D.C. AND AGBO, I.C. 2012. The Effects Of Vaccination, Antibiotic And Vitamin therapy on some clinical parameters associated with natural outbreak of fowpox in chickens. J. of Vet. Med. And Anim. Heal., Vol. (9), PP. 136-139.

PAOLETTI, E. 1990.  Poxvirus recombinant vaccines. Ann. N. Y. Acad. Sci. 590:309–325.

QIAO CL., YU KZ., JIANG YP, JIA YQ., TIAN GB., LIU M., DENG GH. AND TANG XY. 2003. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol. 32(1):25-32.

RADAELLI, A., C. ZANOTTO, G. PERLETTI, V. ELLI, E. VICENZI, G. POLI, AND C. DE GIULIMORGHEN. 2003. Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination protocols against SHIV. Vaccine, 21:2052–2064.

REED, L.J. AND MUNECH, H. 1938. A simple method of estimating fifty percent  end points. Am. J. Hyg, 27:493-497.

RICHARD-MAZET A., GOUTEBROZE S., LE GROS F-X., SWAYNE D.E. AND BUBLOT M. 2016. Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies. Vet. Res., 45:107.

SELIM,  A., ERFAN,  A., HAGAG, N., ZANATY, A., SAMIR, A.H., SAMY, M., ABDELHALIM, A. ARAFA, A.A., SOLIMAN, M., SHAHEEN, M., IBRAHEEM, E., MAHROUS, I., HASSAN, M., AND NAGUIB, M. 2017. Highly pathogenic avian influenza virus (H5N8) Clade 2.3.4.4 infection in migratory birds, Egypt. Emerg. Infect. Dis., 23(6): 1048-1051.

SIDDIQUE, A. B., HOSSAIN, F. M. A.  ANDZINNAHM. A. 2011. Determination of host specificity of pigeon pox and fowl pox viruses isolated from a field outbreak. Bulgarian Journal of Veterinary Medicine, 14, No 4, 209−214.

STEENSELS, M., BUBLOT, M., VAN S., BORM, B. , DE VRIESE, J. L., RICHARD-MAZET, A., CHANAVAT- BIZZINI, S., DUBOEUF, M., LE GROS, F.-X.AND BERG, T. 2008. Search ScienceDirecthttps://doi.org/10.1016/j.vaccine..11.044. Outline Purchase PDFP urchaseExport AdvancedGet rights and content.

SWAYNE DE, SUAREZ DL, SPACKMAN E, JADHAO S, DAUPHIN G, KIM-TORCHETTI M. 2015. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia. Journal of Virology. 89:3746–62. 

TASLIMA, A., SHAHIDUR M., PAUL N., KAFI, A., SHIL, N. ANDSIDDIQUE M. 2008. Persistence of Maternally Derived Antibody in selected group of chicks to fowl pox virus. Bangladesh J. Micro., Vol. 25(1):57-59.

TAYLOR, J., TRIMARCHI, C., WEINBERG, R., LANGUET, B., GUILLEMIN, F., DESMETTRE, P.AND PAOLETTI, E. 1991. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine, 9:190-193.

TAYLOR, J., WEINBERG, R., LANGUET, B., DESMETTRE, P. AND PAOLETTI, E. 1988. Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine, 6:497–503.

TAYLOR, J., WEINBERG, R., TARTAGLIA, J., RICHARDSON, C., ALKHATIB, G., BRIEDIS, D., APPEL, M., NORTON, E. AND PAOLETTI, E. 1992. Non replicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology, 187, 321-328.

TRIPATHY D.N. AND REED W.N. 2003. Disease of Poultry. 11th ed. Pox ,p.253-269.Blackwell Publishing Ames, Iowa.

TRIPATHY D.N. AND REED W.N. 2008. Disease of Poultry. 12th ed. Pox ,p.291-308.Blackwell Publishing Ames, Iowa.

TUMPEY T. M., KAPCZYNSKI D. R. AND SWAYNE D.E. 2004. Comparative susceptibility of chickens and turkeys to avian influenza A H7N2 virus infection and protective efficacy of a commercial avian influenza H7N2 virus vaccine. Avian Dis., 48167-176.

WANG, J.; MEERS, J.; SPRADBROW, P. B. AND ROBINSON, W. F. 2006. Evaluation of immune effects of fowl pox vaccine strains and field isolates. Vet. Microbial, 116: 106 – 119.

WEBSTER, R. G., TAYLOR, J., PEARSON, J., RIVERA, E. AND PAOLETTI, E. 1996. Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant. Avian Dis40, 461-465.

 WEBSTER, S. J., DUNACHIE, D. P., VUOLA, S., BERTHOUD, J. M., KEATING,T., LAIDLAWS., MCCONKEY, S. M., POULTON, I., ANDREWS,L., L. ANDERSEN, L., BEJON, P., BUTCHER, G., SINDEN,R. , SKINNER,M. A. , GILBERT, S. C. AND HILL, A. V.  2005. Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc. Natl. Acad. Sci. USA 102:4836–4841.

WELI S.C AND TRYLAND M. 2011. Avipoxviruses; infection biology and their use as vaccine vectors. Review. Virology Journal. 8:49.

WHO: WORLD HEALTH ORGANIZATION 2008. H5N1 avian influenza.timeline of major events, Available from http://www.who.int/csr/disease/ avian_influenza/Timeline_07_Aug27.pdf.

Statistics
Article View: 1,837
PDF Download: 641